Articles published by Amprion

Amprion Partners with MLM Medical Labs to Expand Alpha-Synuclein SAA Testing in Europe

August 12, 2026

From Amprion

Via Business Wire

Amprion and Modality.AI Break New Ground in Multimodal Assessment for Neurodegenerative Disease

July 09, 2026

From Amprion

Via Business Wire

Amprion Grows Global Footprint with Australian Partnership & Expanded Research Collaborations

April 01, 2026

From Amprion

Via Business Wire

Amprion Announces Strategic Growth Initiatives, Expanding Access to Breakthrough SAAmplify Test

July 23, 2025

From Amprion

Via Business Wire

Amprion Announces Landmark Study in The Lancet Neurology

November 21, 2024

From Amprion

Via Business Wire

Amprion Honored to Win the 2024 BioTech Breakthrough Award ‘Clinical Diagnostics Solution of the Year’

November 19, 2024

From Amprion

Via Business Wire

Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic Diagnostics

October 09, 2024

From Amprion

Via Business Wire

FDA Issues Letter of Support for α-Synuclein Seed Amplification Assay – The Core Technology Used in Amprion’s First Commercial Test

September 05, 2024

From Amprion

Via Business Wire

Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024

July 26, 2024

From Amprion

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.